Harmony Biosciences Holdings 10K Form
Harmony Biosciences Holdings
7 Day Trial
ALL ACCESS PASS
10K form not available
Receive HRMY News And Ratings
See the #1 stock for the next 7 days that we like better than HRMY
HRMY Financial Statistics
Sales & Book Value
|Price / Cash Flow:||13.63|
|Price / Book:||4.76|
|Net Income (TTM):||$189.47M|
|Return on Equity:||57.39%|
|Return on Assets:||31.56%|
Harmony Biosciences Holdings Earnings Forecast
Key Harmony Biosciences Holdings Financial Ratios
- The Gross Profit Margin over the past 5 years for HRMY is 80.93%.
- The Selling, General & Administrative Expenses for HRMY have been equal to 37.30% of Gross Profit Margin.
- The Research & Development expenses have been 16.19% of Revenue.
- The Interest Expense is 8.64% of Operating Income.
- The Net Earning history of HRMY is 41.44% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Harmony Biosciences Holdings Stock Price Chart
Industry, Sector and Symbol
|Trailing P/E Ratio:||11.85|
|Forward P/E Ratio:||8.18|
HRMY Technical Analysis vs Fundamental Analysis
Harmony Biosciences Holdings (HRMY) is a Sell
Is Harmony Biosciences Holdings a Buy or a Sell?
Harmony Biosciences Holdings stock is rated a Sell
The current Harmony Biosciences Holdings [HRMY] share price is $35.19. The Score for HRMY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.